Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-5.79 Insider Own25.52% Shs Outstand9.60M Perf Week-16.32%
Market Cap86.37M Forward P/E- EPS next Y-3.06 Insider Trans86.16% Shs Float7.65M Perf Month-7.58%
Income-38.99M PEG- EPS next Q-0.96 Inst Own4.17% Short Float1.12% Perf Quarter111.31%
Sales0.00M P/S- EPS this Y47.20% Inst Trans-2.78% Short Ratio1.40 Perf Half Y51.26%
Book/sh0.48 P/B17.65 EPS next Y16.60% ROA-117.72% Short Interest0.09M Perf Year2.56%
Cash/sh1.22 P/C6.90 EPS next 5Y- ROE-175.11% 52W Range2.96 - 24.39 Perf YTD0.84%
Dividend Est.- P/FCF- EPS past 5Y3.87% ROI-365.75% 52W High-65.52% Beta0.68
Dividend TTM- Quick Ratio2.37 Sales past 5Y162.73% Gross Margin- 52W Low184.12% ATR (14)0.89
Dividend Ex-Date- Current Ratio2.37 EPS Y/Y TTM97.57% Oper. Margin0.00% RSI (14)42.74 Volatility12.80% 8.68%
Employees32 Debt/Eq1.37 Sales Y/Y TTM-100.00% Profit Margin- Recom2.00 Target Price10.00
Option/ShortNo / Yes LT Debt/Eq1.19 EPS Q/Q23.59% Payout- Rel Volume0.87 Prev Close8.85
Sales Surprise- EPS Surprise-5.50% Sales Q/Q- EarningsMay 15 AMC Avg Volume60.95K Price8.41
SMA20-9.87% SMA50-1.07% SMA20019.95% Trades Volume52,950 Change-4.97%
May-23-24 05:30PM
May-16-24 06:02AM
May-15-24 10:53PM
Apr-25-24 08:30AM
04:30PM Loading…
Apr-05-24 04:30PM
Apr-02-24 07:53AM
Mar-29-24 08:30AM
Mar-18-24 08:00AM
Mar-06-24 08:30AM
Feb-05-24 08:30AM
Jan-25-24 09:00AM
Jan-17-24 08:30AM
Jan-16-24 08:30AM
Jan-11-24 08:30AM
08:26AM Loading…
Jan-09-24 08:26AM
Dec-22-23 09:00AM
Dec-04-23 08:00AM
Nov-09-23 04:30PM
Nov-03-23 04:30PM
Oct-11-23 08:00AM
Sep-27-23 05:30PM
Sep-07-23 08:00AM
Sep-06-23 08:00AM
Sep-05-23 08:00AM
Aug-28-23 08:00AM
Aug-22-23 04:30PM
Aug-11-23 08:30AM
Aug-09-23 08:00AM
08:00AM Loading…
Jun-06-23 08:00AM
Jun-03-23 09:00AM
Jun-02-23 04:30PM
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chudnovsky YekaterinaDirectorDec 22 '23Buy5.811,213,0007,047,5301,915,639Dec 26 04:29 PM